Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 14/20 | 0.73 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | BRD1 | O95696 | 1/20 | 0.43 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10318681 | 0.93 | AXL (0.64) | AXLMRGPRX1ALDH1A1MAPT | |
| SCHEMBL10317039 | 0.93 | AXL (0.63) | AXLMRGPRX1POLBGAASMN1; SMN2 | |
| SCHEMBL10319493 | 0.90 | AXL (0.60) | AXLMRGPRX1POLBGAASMN1; SMN2 | |
| SCHEMBL10317118 | 0.90 | AXL (0.59) | AXLMRGPRX1POLBGAASMN1; SMN2 | |
| SCHEMBL10316977 | 0.89 | AXL (0.75) | AXL | |
| SCHEMBL10319409 | 0.88 | AXL (0.72) | AXLMRGPRX1 | |
| SCHEMBL10317543 | 0.88 | AXL (0.75) | AXLMRGPRX1ALDH1A1MAPT | |
| SCHEMBL10317695 | 0.87 | AXL (0.58) | AXLMRGPRX1POLBALDH1A1MAPT | |
| SCHEMBL10319281 | 0.87 | AXL (0.73) | AXLPOLB | |
| SCHEMBL10317131 | 0.87 | AXL (0.73) | AXLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2262772-B1 | QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS | MAX PLANCK GESELLSCHAFT (DE) | 2012-07-18 | — | — | EP | claimed |